BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12612078)

  • 21. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
    Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
    J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
    J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation.
    Liao W; Tang Y; Lin SF; Kung HJ; Giam CZ
    J Virol; 2003 Mar; 77(6):3809-15. PubMed ID: 12610155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    Lan K; Kuppers DA; Robertson ES
    J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization.
    Bu W; Palmeri D; Krishnan R; Marin R; Aris VM; Soteropoulos P; Lukac DM
    J Virol; 2008 Nov; 82(21):10709-23. PubMed ID: 18715905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
    PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.
    Palmeri D; Spadavecchia S; Carroll KD; Lukac DM
    J Virol; 2007 Dec; 81(24):13299-314. PubMed ID: 17913801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Ellison TJ; Izumiya Y; Izumiya C; Luciw PA; Kung HJ
    Virology; 2009 Apr; 387(1):76-88. PubMed ID: 19269659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression.
    Kaul R; Purushothaman P; Uppal T; Verma SC
    PLoS One; 2019; 14(4):e0215394. PubMed ID: 30998737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
    Yang Z; Yan Z; Wood C
    J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element.
    Liu Y; Cao Y; Liang D; Gao Y; Xia T; Robertson ES; Lan K
    Virology; 2008 Oct; 380(2):264-75. PubMed ID: 18786687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.
    Lukac DM; Kirshner JR; Ganem D
    J Virol; 1999 Nov; 73(11):9348-61. PubMed ID: 10516043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
    Spires LM; Wind E; Papp B; Toth Z
    J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
    Li S; Hu H; He Z; Liang D; Sun R; Lan K
    PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs.
    Liao W; Tang Y; Kuo YL; Liu BY; Xu CJ; Giam CZ
    J Virol; 2003 Sep; 77(17):9399-411. PubMed ID: 12915555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae.
    Staudt MR; Dittmer DP
    Curr Top Microbiol Immunol; 2007; 312():71-100. PubMed ID: 17089794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.
    Guito J; Gavina A; Palmeri D; Lukac DM
    J Virol; 2014 Jan; 88(1):547-58. PubMed ID: 24173213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.